1,544
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Mitochondrial N-formyl methionine peptides contribute to exaggerated neutrophil activation in patients with COVID-19

, , , , , , , , , , , & ORCID Icon show all
Article: 2218077 | Received 24 Mar 2023, Accepted 20 May 2023, Published online: 29 May 2023

References

  • Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19. Front Immunol. 2020;11:827.
  • Kulkarni-Munje A, Palkar S, Shrivastava S, et al. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity, Immun. Immunity Inflam & Disease. 2021;9:419–12.
  • Carsetti R, Zaffina S, Piano Mortari E, et al. Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases. Front Immunol. 2020;11:610300.
  • Zhang B, Zhou X, Zhu C, et al. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 2020;7:157.
  • Reusch N, De Domenico E, Bonaguro L, et al. Neutrophils in COVID-19, Front. Immunol. 2021 [accessed August 19, 2022];12. https://www.frontiersin.org/articles/10.3389/fimmu.2021.652470
  • Hazeldine J, Lord JM. Neutrophils and COVID-19: active participants and rational therapeutic targets, front. Immunol. 2021 [accessed August 19, 2022];12. https://www.frontiersin.org/articles/10.3389/fimmu.2021.680134
  • Narasaraju T, Tang BM, Herrmann M, et al. Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19. Front Pharmacol. 2020;11:870.
  • Chua RL, Lukassen S, Trump S, et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38:970–979.
  • Liao M, Liu Y, Yuan J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26:842–844.
  • Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81:e6–e12.
  • Gong J, Dong H, Xia Q-S, et al. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infect Dis. 2020;20:963.
  • Meizlish ML, Pine AB, Bishai JD, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5:1164–1177.
  • Aschenbrenner AC, Mouktaroudi M, Krämer B, et al. German COVID-19 Omics Initiative (DeCOI), Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 2021;13:7.
  • Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5:1317–1327.
  • Jenne CN, Wong CHY, Zemp FJ, et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe. 2013;13:169–180.
  • Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Bio. 2007;176:231–241.
  • Bartáková E, Štefan M, Stráníková A, et al. Calprotectin and calgranulin C serum levels in bacterial sepsis, Diagn. Microbiol Infect Dis. 2019;93:219–226.
  • Colón DF, Wanderley CW, Franchin M, et al. Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis. Crit Care. 2019;23:113.
  • Mikacenic C, Moore R, Dmyterko V, et al. Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia. Crit Care. 2018;22. 10.1186/s13054-018-2290-8.
  • Bach M, Moon J, Moore R, et al. A neutrophil activation biomarker panel in prognosis and monitoring of patients with rheumatoid arthritis. Arthritis & Rheumat. 2020;72:47–56.
  • Kuley R, Stultz RD, Duvvuri B, et al. N-Formyl methionine peptide-mediated neutrophil activation in systemic sclerosis, front. Immunol. 2022 [accessed April 7, 2022];12. https://www.frontiersin.org/article/10.3389/fimmu.2021.785275
  • Moore S, Juo H-H, Nielsen CT, et al. Role of neutrophil extracellular traps regarding patients at risk of increased disease activity and cardiovascular comorbidity in systemic lupus erythematosus. J Rheumatol. 2020;47:1652–1660.
  • Tydén H, Lood C, Gullstrand B, et al. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus. Lupus. 2017;26:139–149.
  • Middleton EA, He X-Y, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169–1179.
  • Dennison D, Al Khabori M, Al Mamari S, et al. Circulating activated neutrophils in COVID-19: an independent predictor for mechanical ventilation and death. Int J Infect Dis. 2021;106:155–159.
  • Rawat S, Vrati S, Banerjee A. Neutrophils at the crossroads of acute viral infections and severity, Mol. Aspects Med. 2021;81:100996.
  • Brandes M, Klauschen F, Kuchen S, et al. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell. 2013;154:197–212.
  • Jaovisidha P, Peeples ME, Brees AA, et al. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol Baltim Md. 1950;163(1999):2816–2820.
  • Speth C, Brodde MF, Hagleitner M, et al. Neutrophils turn plasma proteins into weapons against HIV-1. PLoS ONE. 2013;8:e66073.
  • Duvvuri B, Baddour AA, Deane KD, et al. Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis. J Autoimmun. 2021;119:102630.
  • Michailidou D, Duvvuri B, Kuley R, et al. Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis, Arthritis Res. Ther. 2022;24:160.
  • Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med. 1982;155:264–275.
  • Dorward DA, Lucas CD, Chapman GB, et al. The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation. Am J Pathol. 2015;185:1172–1184.
  • Najafi S, Rajaei E, Moallemian R, et al. The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach, Clin. Rheumatol. 2020;39:3223–3235.
  • Bhatraju PK, Morrell ED, Zelnick L, et al. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study. Crit Care. 2021;25:148.
  • Marshall JC, Murthy S, Diaz J, et al. COVID-19 infection, a minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192–e197. of. 10.1016/S1473-3099(20)30483-7
  • Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22:146–153.
  • Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. Nets are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5:178ra40.
  • Michailidou D, Johansson L, Kuley R, et al. Immune complex-mediated neutrophil activation in patients with polymyalgia rheumatica. Rheumatology. 2022;keac722. 10.1093/rheumatology/keac722
  • Weiß E, Kretschmer D. Formyl-peptide receptors in infection, inflammation, and cancer. Trends Immunol. 2018;39:815–829.
  • Grommes J, Drechsler M, Soehnlein O. CCR5 and FPR1 mediate neutrophil recruitment in endotoxin-induced lung injury. J Innate Immun. 2014;6:111–116.
  • Paola RD, Fusco R, Gugliandolo E, et al. Formyl peptide receptor 1 signalling promotes experimental colitis in mice, Pharmacol. Res. 2019;141:591–601.
  • Cardini S, Dalli J, Fineschi S, et al. Genetic ablation of the fpr1 gene confers protection from smoking-induced lung emphysema in mice. Am J Respir Cell Mol Biol. 2012;47:332–339.
  • Leslie J, Millar BJM, Del C Pons A, et al. FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis. JCI Insight. 2020;5. 10.1172/jci.insight.125937.
  • Shrivastava S, Chelluboina S, Jedge P, et al. Elevated levels of neutrophil activated proteins, alpha-defensins (DEFA1), calprotectin (S100A8/A9) and myeloperoxidase (MPO) are associated with disease severity in COVID-19 patients, front. Cell Infect Microbiol. 2021 [accessed June 13, 2022];11. https://www.frontiersin.org/article/10.3389/fcimb.2021.751232
  • Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5. 10.1172/jci.insight.138999
  • Zuo Y, Zuo M, Yalavarthi S, et al. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis. 2021;51:446–453.
  • Toma L, Dodot M, Zgura A, et al. Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus, Clin. Exp Med. 2022;22:311–317.
  • Kaya T, Yaylacı S, Nalbant A, et al. Serum calprotectin as a novel biomarker for severity of COVID-19 disease. Ir J Med Sci. 2022;191:59–64.
  • Luque-Garcia JL, Neubert TA. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. J Chromatogr A. 2007;1153:259–276.
  • Sur Chowdhury C, Giaglis S, Walker UA, et al. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility, Arthritis Res. Ther. 2014;16:R122.
  • Pierrakos C, Karanikolas M, Scolletta S, et al. Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res. 2012;4:7–16.
  • Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical. ARDS? Crit Care Lond Engl. 2020;24:198.
  • Aslan A, Aslan C, Zolbanin NM, et al. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia. 2021;13:14.
  • Bain W, Yang H, Shah FA, et al., COVID-19 versus non–COVID-19 acute respiratory distress syndrome: comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes. Ann Am Thorac Soc. 2021;18:1202–1210. 10.1513/AnnalsATS.202008-1026OC.
  • Robinson JM. Reactive oxygen species in phagocytic leukocytes. Histochem Cell Biol. 2008;130:281–297.
  • Tardif MR, Chapeton-Montes JA, Posvandzic A, et al. Secretion of S100A8, S100A9, and S100A12 by neutrophils involves reactive oxygen species and potassium efflux. J Immunol Res. 2015;2015(2015):1–16.
  • Shi H, Zuo Y, Yalavarthi S, et al. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. MedRxiv. 2020. 10.1101/2020.05.06.20093070
  • Ehrchen JM, Sunderkötter C, Foell D, et al. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukocyte Biol. 2009;86:557–566.
  • Ehlermann P, Eggers K, Bierhaus A, et al. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products, Cardiovasc. Diabetology. 2006;5:6.
  • Rodriguez-Smith JJ, Verweyen EL, Clay GM, et al. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study. Lancet Rheumatol. 2021;3:e574–e584.
  • García de Guadiana-Romualdo L, Rojas CR, Morell-García D, et al. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study. Inflamm Res. 2022;71:57–67.
  • Schönrich G, Raftery MJ. Neutrophil extracellular traps Go Viral, Front. Immunol. 2016;7:366.
  • Saitoh T, Komano J, Saitoh Y, et al. Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe. 2012;12:109–116.
  • Veras FP, Pontelli CM, Silva JE, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217:e20201129.
  • Veras FP, Gomes GF, Silva BMS, et al. 2023. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model, Respir. Res 24. 66. 10.1186/s12931-023-02336-2
  • Panda R, Castanheira FV, Schlechte JM, et al. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies. JCI Insight. 2022;7:e152291.
  • Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007;13:463–469.
  • Matsumoto K, Yasuoka H, Yoshimoto K, et al. Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis. Sci Rep. 2021;11:222.
  • Sigurdsson MI, Kobayashi H, Amrein K, et al. Circulating N-formylmethionine and metabolic shift in critical illness: a multicohort metabolomics study. Crit Care. 2022;26:321.